Purpose: Although hepatectomy is an established curative treatment for hepatocellular carcinoma (HCC), early recurrence is common. We defined recurrence within 6 months after hepatectomy as early recurrent HCC. The aim of this retrospective study was to evaluate the features and predictive factors of early recurrent HCC after hepatectomy.
Method: We enrolled 93 patients who underwent hepatectomy as initial treatment for HCC from January 2005 to June 2012. These patients were divided into two groups. Twelve (12.9%) were in the early recurrence group (ERG) and, 81 (87.1%) were in the non-early recurrence group (NERG). We compared these groups clinicopathologically.
Results: The median time to recurrence in the ERG was 3.5 months (1–5 months), and the median overall survival was 13 months. The 3-year survival rates were 30.6% and 90.8% in the ERG and NERG, respectively (
P<0.001). According to a multivariate analysis, the only factor predicting early recurrence was the tumor stage (
P=0.008), and the cut-off was stage III disease. We compared patients in the ERG and NERG within stage III and IVa HCC. In multivariate analysis, there were no significant differences between the groups, but in univariate analysis, an AFP ≥43 ng/ml (
P=0.004) and the presence of a capsule defect (
P=0.004) were factors predicting early recurrence.
Conclusion: Patients with stage III or stage IVa HCC, an AFP value ≥43 ng/ml and capsule defect are likely to have early recurrence and a poor prognosis after hepatectomy.
View full abstract